Marine natural products and their potential applications as anti-infective agents
- PMID: 12781505
- PMCID: PMC7106398
- DOI: 10.1016/s1473-3099(03)00655-8
Marine natural products and their potential applications as anti-infective agents
Abstract
The oceans are a unique resource that provide a diverse array of natural products, primarily from invertebrates such as sponges, tunicates, bryozoans, and molluscs, and from marine bacteria and cyanobacteria. As infectious diseases evolve and develop resistance to existing pharmaceuticals, the marine environment provides novel leads against fungal, parasitic, bacterial, and viral diseases. Many marine natural products have successfully advanced to the late stages of clinical trials, including dolastatin 10, ecteinascidin-743, kahalalide F, and aplidine, and a growing number of candidates have been selected as promising leads for extended preclinical assessment. Although many marine-product clinical trials are for cancer chemotherapy, drug resistance, emerging infectious diseases, and the threat of bioterrorism have all contributed to the interest in assessing natural ocean products in the treatment of infectious organisms. In this review, we focus on the pharmacologically tested marine leads that have shown in-vivo efficacy or potent in-vitro activity against infectious and parasitic diseases.
Figures







References
-
- Jimeno JM. A clinical armamentarium of marine-derived anti-cancer compounds. Anticancer Drugs. 2002;13(suppl 1):S15–S19. - PubMed
-
- Pomponi SA. The bioprocess-technological potential of the sea. J Biotechnol. 1999;70:5–13.
-
- Ireland CM, Copp BR, Foster MP, McDonald LA, Radisky DC, Swersey JC. Bioactive compounds from the sea. In: Martin RE, Carter EP, Davis LM, editors. Marine and freshwater products handbook. Technomic Publishing; Lanceaster. PA: 2000. pp. 641–661.
-
- Konig GM, Wright AD, Sticher O, Angerhofer CK, Pezzuto JM. Biological activities of selected marine natural products. Planta Med. 1994;60:532–537. - PubMed
-
- Faulkner DJ. Marine natural products. Nat Prod Rep. 2001;18:1–49. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials